James Lynch
Hospitalist · Edmond, OKNPI 1366485229
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 176 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 20.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,231 and has fallen 93.0% since, to $155 in 2025. Among hospitalist clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 176 payments — averaging $17.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$633
- Amgen$385
- Tersera Therapeutics LLC$256
- Pfizer$219
- Lilly USA, LLC$212
- MDD US Operations, LLC$169
- plus $1K from 24 others
What the payments were for
- Travel & lodging$40%
- Food & beverage$3,087100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 6 | $633 |
| Amgen(2 entities) | 21 | $385 |
| Tersera Therapeutics LLC | 21 | $256 |
| Pfizer | 19 | $219 |
| Lilly USA, LLC | 13 | $212 |
| MDD US Operations, LLC | 9 | $169 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $157 |
| Collegium Pharmaceutical, Inc. | 10 | $140 |
| Biodelivery Sciences International, Inc. | 21 | $128 |
| Johnson & Johnson | 1 | $122 |
| Scilex Pharmaceuticals Inc. | 8 | $119 |
| Sentynl Therapeutics, Inc. | 6 | $76 |
| Medtronic | 2 | $65 |
| Orexo US, Inc. | 4 | $59 |
| AstraZeneca | 4 | $48 |
| Pacira Therapeutics, Inc. | 3 | $44 |
| Novo Nordisk | 2 | $38 |
| Promius Pharma LLC | 2 | $30 |
| Boehringer Ingelheim | 1 | $26 |
| Assertio Therapeutics, Inc. | 2 | $24 |
| Zyla Life Sciences, Inc. | 2 | $23 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Kaleo, Inc. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Merck | 1 | $13 |
| Pernix Therapeutics Holdings, Inc. | 1 | $12 |
| Shionogi Inc | 1 | $12 |
| Vertical Pharmaceuticals, LLC | 1 | $12 |
| Avanir Pharmaceuticals, Inc. | 1 | $12 |
| Arbor Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,091 in reported general payments places this provider in the 95th percentile of 234 hospitalist providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 87 | $16,107 |
| Buprenorphine Hcl | 39 | $1,303 |
| Hydroxyzine Hcl | 23 | $297 |
| Tizanidine Hcl | 12 | $97 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Edmond
- Jeffery PruittEdmond$959
- Kishen PatelTulsa$4K
- Mark ThngTulsa$4K
- Zubair AshrafOklahoma City$4K
- Jawad BabarTulsa$2K
- Steven DanleyOklahoma City$2K
- Timothy CookOklahoma City$2K
- Bhavik PatelTulsa$2K
- Soumya KidiyoorMuskogee$1K
- Deepak KaribassappaMuskogee$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.